Company profile
SURFACtoBioTech
SURFACtoBioTech is developing an experiment miniaturization platform to enable labs to run fast and reliable tests.
- Industry
- Biotechnology Research
- Employees
- 7
- Headquarters
- Hamburg, Hamburg
- Founded
- 2024
- LinkedIn followers
- 589
- Office locations
- 1
SURFACtoBioTech company summary
SURFACtoBioTech is a company in the Biotechnology Research industry, headquartered in Hamburg, Hamburg, founded in 2024. On LinkedIn the company has around 7 employees and 589 followers.
What technology does SURFACtoBioTech use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About SURFACtoBioTech
SURFACtoBioTech is transforming biotechnology research with peak-performance surfactants and instrumentation that make experiments faster, more efficient, and sustainable. We are a Max Planck Innovation spin-off shifting the paradigm in the biotech industry by solving critical challenges in the commercialization of droplet-based microfluidics. Our chemically engineered surfactants deliver exceptional performance while our instruments dramatically reduce operational complexity and costs compared to competitors. We make it easy for more people to make the transition to droplet-based approaches that will first change the way scientists do experiments and eventually change the way data is digitalized. We have first reference customers in the field of protein crystallography and are working towards expanding our reach into other relevant markets. Problem Traditional lab experiments in biotechnology, such as those conducted in well plates, are resource-intensive, costly, and inefficient. Droplet-based microfluidics offers a disruptive solution but faces barriers like unstable emulsions, inadequate surfactants, complex setups, and scarce workforces, leading to frequent failures. Solution SURFACtoBioTech provides an application-optimized droplet platform that automates and simplifies droplet-based microfluidics. This enables efficient, reliable, and sustainable experiments, reducing reagent use and costs while boosting data quality and quantity. We enable ultrahigh-throughput data generation, amenable to training AI bio-analytics. Business model SURFACtoBioTech generates revenue through three streams: automated instruments, chemically engineered surfactants, and AI-bioanalytic software, serving academic labs, clinical centers, and pharma companies globally.
Where is SURFACtoBioTech located?
SURFACtoBioTech lists 1 location.
Compare companies similar to SURFACtoBioTech
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
SURFACtoBioTech surfactobio.tech | Biotechnology Research | 7 | 2024 | Hamburg, Hamburg |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about SURFACtoBioTech
What does SURFACtoBioTech do?
SURFACtoBioTech is transforming biotechnology research with peak-performance surfactants and instrumentation that make experiments faster, more efficient, and sustainable. We are a Max Planck Innovation spin-off shifting the paradigm in the biotech industry by solving critical challenges in the commercialization of droplet-based microfluidics. Our chemically engineered surfactants deliver exceptional performance while our instruments dramatically reduce operational complexity and costs compared to competitors. We make it easy for more people to make the transition to droplet-based approaches that will first change the way scientists do experiments and eventually change the way data is digitalized. We have first reference customers in the field of protein crystallography and are working towards expanding our reach into other relevant markets. Problem Traditional lab experiments in biotechnology, such as those conducted in well plates, are resource-intensive, costly, and inefficient. Droplet-based microfluidics offers a disruptive solution but faces barriers like unstable emulsions, inadequate surfactants, complex setups, and scarce workforces, leading to frequent failures. Solution SURFACtoBioTech provides an application-optimized droplet platform that automates and simplifies droplet-based microfluidics. This enables efficient, reliable, and sustainable experiments, reducing reagent use and costs while boosting data quality and quantity. We enable ultrahigh-throughput data generation, amenable to training AI bio-analytics. Business model SURFACtoBioTech generates revenue through three streams: automated instruments, chemically engineered surfactants, and AI-bioanalytic software, serving academic labs, clinical centers, and pharma companies globally.
How many employees does SURFACtoBioTech have?
SURFACtoBioTech has around 7 employees on LinkedIn.
Where is SURFACtoBioTech headquartered?
SURFACtoBioTech is headquartered in Hamburg, Hamburg.
When was SURFACtoBioTech founded?
SURFACtoBioTech was founded in 2024.
Build a lead list from companies like SURFACtoBioTech
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.